ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common vitamin speed up stem cell recovery?
Disease control Recruiting nowThis study tests whether a vitamin B3 supplement called nicotinamide riboside (NR) is safe and tolerable for people receiving a donor stem cell transplant. The goal is to see if NR can help the new stem cells settle in faster and reduce recovery time. About 20 participants will t…
Matched conditions: ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
Phase: EARLY_PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Precision dosing could make stem cell transplants safer for Non-Cancer patients
Disease control Recruiting nowThis trial investigates whether giving a personalized dose of alemtuzumab (a drug that calms the immune system) before a stem cell transplant can improve outcomes for people with non-malignant diseases. Researchers aim to find the right dose that balances effectiveness and safety…
Matched conditions: ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC